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Magnetite (Fe3O4) nanoparticles stabilised by sulfonato-
calixarene macrocycles are readily accessible by a rapid in situ
co-precipitation, and exhibit ferro-fluidic and superparamag-
netic behaviour.
Superparamagnetic magnetite (Fe3O4) nanoparticles have been
widely studied for various scientific and technological applications
such as magnetic storage media,1 contrast agents for magnetic
resonance imaging (MRI),2 biolabelling and separation of
biomolecules,3 and magnetic targeted drug delivery.4 All these
applications require the magnetic nanoparticles to be chemically
stable, have particle size ,20 nm with a narrow size distribution,
and to be well dispersed in aqueous medium.5 Preparation of
stable magnetic nanoparticles is a challenge as the particles have
large surface area to volume ratios and thus they tend to aggregate
to reduce their surface energy. In addition, there are strong
magnetic dipole–dipole attractions between the particles that also
cause the particles to aggregate.
Tetramethylammonium hydroxide (TMAOH) is well known as
a surfactant to stabilize such magnetite nanoparticles.6 However,
TMAOH is highly basic and is not biocompatible. Stabilization of
magnetic nanoparticles can also be achieved by coating the particle
surfaces with organic surfactants or polymers. Oleic acid7 and
lauric acid8 are commonly used for this purpose. Khalafalla and
Reimers9 and Wooding et al.10 have stabilised suspensions of
magnetite using various saturated and unsaturated fatty acids as
primary and secondary surfactants. Synthetic polymers and
biopolymers have also been used to coat and stabilize magnetic
nanoparticles. Examples of the former include poly(vinyl
alcohol),11 poly(acrylic acid),12 and triblock co-polymers (PEO–
COOH–PEO).13 Among the biopolymers used to stabilize
magnetite nanoparticles are dextran14 and alginic acid.15 Most of
this work involves adding the surfactant to the preformed
magnetite nanoparticles.
One of the drawbacks of the above approach is that the particle
size distribution is difficult to control, and the process is time-
consuming requiring further work up. On the other hand, the
synthesis of magnetite nanoparticles in the presence of a surfactant
can circumvent aggregation and control the size of the nano-
particles. Yaacob et al. have prepared magnetite nanoparticles at
room temperature ,15 nm in diameter with a narrow size
distribution of the particles which are inside vesicles based on a
variety surfactants, namely cetyltrimethylammonium bromide
(CTAB) and dedecylbenzenesulfonic acid (DBSA).16
p-Sulfonato-calix[n]arenes are cyclic phenolic oligomers with a
hydrophobic cavity, which can form host–guest inclusion com-
plexes in a similar way to cyclodextrins. Such water soluble
calixarenes display interesting biological properties such as anti-
viral and anti-bacterial activity,17 and form inclusion complexes
with a variety of small molecules.18 Complexes with hydrophobic
drugs impart increased solubility of the drug molecules in aqueous
medium.19 Complexation of Bovine Serum Albumin (BSA), an
arginine- and lysine-rich protein, with sulfonato calixarenes has
been demonstrated by Memmi et al.20 Furthermore, both in vitro
and in vivo toxicity studies show that sulfonato-calixarenes have
low toxicity.21 Overall, p-sulfonato-calixarenes have potential for
biomedical applications, and in this context we note that
sulfonato-calix[4,5,6,8]arenes act as surfactants in stabilizing
trans-b-carotene nanoparticles.22
In this study we report the stabilization of superparamagnetic
magnetite nanoparticles by coating them with p-sulfonato-calix[6
and 8]arenes, 1, n = 6,8, and sulfonated p-benzylcalix[4,5,6 and
8]arenes, 2, n = 4,5,6,8, Fig. 1.{ Remarkably, stable ferrofluids are
formed by a rapid and simple in situ co-precipitation from a
solution of Fe(II) and Fe(III) chloride in the appropriate ratio, with
aqueous ammonia, in the presence of the p-sulfonato-calixarenes
and sulfonated p-benzylcalixarenes. The calixarenes not only serve
as surfactants to stabilize the magnetite nanoparticles, they also
functionalize the magnetite nanoparticles for potential biomedical
applications, Fig. 1. To the best of our knowledge, this is the first
report in the literature of coating magnetite nanoparticles with
calix[n]arenes.
The formation of superparamagnetic magnetite nanoparticles
was confirmed by SQUID measurements and TEM, while the
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Fig. 1 p-Sulfonato-calix[n]arenes and sulfonato p-benzylcalix[n]arenes
showing a possible mode of interaction of 1, n = 6, at the surface of the
nanoparticles (NPs).
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